The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Agile Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 258.4%.

Top 15 shareholders own 25.52% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.85%	Beryl Capital Management LLC	680,000	US$1.0m	0%	0.22%
8.95%	Roger Klein	618,000	US$933.2k	0%	no data
6.17%	Tang Capital Management, LLC	426,153	US$643.5k	0%	0.06%
0.28%	Alfred Altomari	19,624	US$29.6k	1,430%	no data
0.15%	Geoffrey Gilmore	10,131	US$15.3k	25,200%	no data
0.049%	Paul Korner	3,375	US$5.1k	0%	no data
0.014%	John Hubbard	976	US$1.5k	2,280%	no data
0.014%	Seth H. Fischer	976	US$1.5k	2,280%	no data
0.014%	Josephine Torrente	974	US$1.5k	2,400%	no data
0.014%	Sandra Carson	973	US$1.5k	2,460%	no data
0.014%	Sharon Surrey-Barbari	973	US$1.5k	2,460%	no data
0.0012%	Scott Coiante	80	US$120.9	0%	no data
0.00062%	Bg Fund Management Luxembourg S.A.	43	US$64.6	0%	no data
0.00045%	Ajit S. Shetty	31	US$46.9	0%	no data
0.00042%	Robert Conway	29	US$43.8	0%	no data